Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CONNIE HILL

NPI
1477705507
CMS profile
11311335
Location
JONESBORO, AR

General Payments · PY2021–2024

$3,547.14

  • Reported across 64 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$653.79

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $653.79 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BOSTON SCIENTIFIC CORPORATION $354.25 11
CVRx Inc. $121.32 2
Biosense Webster, Inc. $89.50 1
Acerta Pharma LLC $88.72 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $59.95 3
PY2022 $2,131.15 32
PY2023 $702.25 14
PY2024 $653.79 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $88.72 01/24/2024 Food and Beverage Undisputed 01/23/2026 1126679410 CMS
Biosense Webster, Inc. $89.50 12/05/2024 Food and Beverage Undisputed 01/23/2026 1077654018 CMS
Boston Scientific Corporation $21.80 01/25/2024 Food and Beverage Undisputed 01/23/2026 1092592799 CMS
Boston Scientific Corporation $32.56 01/30/2024 Food and Beverage Undisputed 01/23/2026 1092592807 CMS
Boston Scientific Corporation $80.67 02/13/2024 Food and Beverage Undisputed 01/23/2026 1092592809 CMS
Boston Scientific Corporation $83.85 03/06/2024 Food and Beverage Undisputed 01/23/2026 1092592811 CMS
Boston Scientific Corporation $10.09 03/14/2024 Food and Beverage Undisputed 01/23/2026 1092592791 CMS
Boston Scientific Corporation $22.40 04/03/2024 Food and Beverage Undisputed 01/23/2026 1092592803 CMS
Boston Scientific Corporation $17.46 08/02/2024 Food and Beverage Undisputed 01/23/2026 1092592793 CMS
Boston Scientific Corporation $18.57 08/19/2024 Food and Beverage Undisputed 01/23/2026 1092592797 CMS
Boston Scientific Corporation $18.13 08/27/2024 Food and Beverage Undisputed 01/23/2026 1092592795 CMS
Boston Scientific Corporation $26.49 09/26/2024 Food and Beverage Undisputed 01/23/2026 1092592805 CMS
Boston Scientific Corporation $22.23 10/02/2024 Food and Beverage Undisputed 01/23/2026 1092592801 CMS
CVRx, Inc. $23.70 04/16/2024 Food and Beverage Undisputed 01/23/2026 1153772491 CMS
CVRx, Inc. $97.62 06/13/2024 Food and Beverage Undisputed 01/23/2026 1153772493 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.